SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-033068
Filing Date
2024-03-11
Accepted
2024-03-11 17:03:55
Documents
19
Period of Report
2024-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248506d1_8k.htm   iXBRL 8-K 27833
2 EXHIBIT 99.1 tm248506d1_ex99-1.htm EX-99.1 20950
6 GRAPHIC tm248506d1_ex99-1img004.jpg GRAPHIC 5063
7 GRAPHIC tm248506d1_ex99-1img001.jpg GRAPHIC 14904
8 GRAPHIC tm248506d1_ex99-1img003.jpg GRAPHIC 2059
9 GRAPHIC tm248506d1_ex99-1img002.jpg GRAPHIC 11204
  Complete submission text file 0001104659-24-033068.txt   275367

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20240306.xsd EX-101.SCH 3082
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20240306_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20240306_pre.xml EX-101.PRE 22365
20 EXTRACTED XBRL INSTANCE DOCUMENT tm248506d1_8k_htm.xml XML 3610
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 24738985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)